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Abstract.  The L-selectin homing receptor expressed 
by lymphocytes mediates the initial attachment of 
these cells to high endothelial venules within periph- 
eral lymph nodes. This adhesive interaction is re- 
quired for the migration of B and T  lymphocytes from 
the blood into peripheral  lymph nodes. There is cur- 
rently little information regarding  the nature of the 
factors involved in the regulation of the synthesis and 
expression of L-selectin by lymphocytes. In this re- 
port, the immunomodulatory cytokine interferon-c~ 
(IFN-ot) was shown to markedly upregulate the surface 
density of L-selectin in the established human B lym- 
phoid Daudi cell line and in a  subpopulation of tissue- 
derived human B lymphoid cells. Other cytokines such 
as IFN-3,, tumor necrosis factor-s,  interleukin (IL)- 
1~, IL-2, IL-4, IL-6, and low molecular weight B cell 
growth factor did not affect L-selectin surface expres- 
sion in the model Daudi B cell line.  Upregulation of 
L-selectin surface density in IFN-ot-treated Daudi B 
cells correlated directly with an increase in L-selectin 
mRNA steady state levels and enhanced L-selectin- 
dependent binding to a carbohydrate-based ligand, 
phosphomonoester core polysaccharide. Regulation of 
L-selectin mRNA by IFN-ot had characteristics  similar 
to that of classical IFN-stimulated genes including 
rapid kinetics of induction, protein-synthesis-indepen- 
dent induction,  and sensitivity to tyrosine-kinase in- 
hibitors.  IFN-ot did not upregulate L-selectin mRNA 
levels or surface expression in an IFN-resistant Daudi 
subclone which exhibits a defect in the signal trans- 
duction pathway required for the transcriptional  induc- 
tion of IFN-stimulated genes. These data demonstrate 
a  fundamental role for IFN-o~ in regulating L-selectin 
synthesis and expression in human B lymphoid cells 
and suggest a mechanism whereby this cytokine regu- 
lates the regional trafficking of B cells to peripheral 
lymph nodes. 
T 
hE generation of an active immune response is depen- 
dent on the capacity of lymphocytes to tratfick con- 
tinuously  from the blood into  secondary lymphoid 
organs,  and back to the blood. Lymphocyte migration  into 
secondary lymphoid tissues is initiated by the interaction  of 
tissue-restricted homing receptors on lymphocytes with spe- 
cialized  structures on the luminal  surface of post-capillary 
high endothelial  venules (HEV)  ~ located within  peripheral 
lymph  nodes  and  Peyer's  patches  (Gowans  et  al.,  1964; 
Stamper et al.,  1976; Butcher et al.,  1980). Multiple lines 
of evidence indicate that the L-selectin homing receptor ex- 
pressed on lymphocytes (also known as gp90  Mel-14, LAM-1, 
LECAM-1, Leu-8,  TQ1, and DREG-56 antigen)  is respon- 
sible for mediating the initial attachment of B and T lympho- 
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cytes to HEV within peripheral lymph nodes (for review see 
Lasky,  1992a).  Monoclonal antibodies which bind L-selec- 
tin have been shown to inhibit lymphocyte adhesion  to pe- 
ripheral  lymph node HEV, but not Peyer's patch HEV, in vi- 
tro (Gallatin  et al.,  1983; Kishimoto et al.,  1990; Spertini 
et al., 1991a, b). L-selectin-specific monoclonal antibodies 
also inhibit in vivo localization of lymphocytes to peripheral 
lymph nodes without significantly affecting their trafficking 
to  Peyer's  patches  (Gallatin  et al.,  1983;  Mountz  et al., 
1988).  Moreover,  the level of expression  of L-selectin on 
lymphocytes has been closely correlated with their ability 
to migrate  to peripheral lymph nodes.  Thus,  lymphocytes 
which do not express L-selectin (e.g.,  germinal  center B 
cells and activated T cell clones) fail to attach to peripheral 
lymph node HEV in vitro or home to peripheral lymph nodes 
in vivo (Reichert et al., 1983; Dailey et al., 1985). Finally, 
a definitive role for L-selectin as an organ-specific  homing 
receptor  has  been  established  by  evidence  that  soluble 
L-selectin molecules competitively inhibit lymphocyte bind- 
ing  to  HEV  in  peripheral  lymph  nodes  but  not  Peyer's 
patches (Geoffroy and Rosen, 1989). In addition  to its role 
as a peripheral  lymph node homing receptor,  L-selectin has 
been implicated in pathological processes such as the inflam- 
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tini et al., 1991c) and metastasis of lymphoid-derived tumors 
to peripheral lymph nodes (Gallatin  et al.,  1983; Bargatze 
et al.,  1987; Pals et al.,  1991). 
Differential expression of L-selectin has been observed on 
B  lymphocyte subsets within  various lymphoid compart- 
ments  including  the bone marrow,  peripheral  blood,  and 
secondary lymphoid tissues (Kansas et al.,  1985a,b;  1989; 
Reichert et al.,  1983; Tedder et al.,  1990; Salmi and Jalka- 
nen,  1992),  suggesting  that the expression  of this  homing 
receptor is tightly regulated during B cell development.  The 
regulatory mechanisms  that generate B lymphocyte subsets 
with tissue-selective  homing  properties are unknown.  Al- 
though it has been speculated that factors such as cytokines 
present in lymphoid tissue microenvironments  differentially 
control L-selectin gene expression,  to date, no cytokine has 
been shown to directly modulate L-selectin expression  or 
function  in B lymphocytes. 
The cytokine interferon-or  (IFN-a),  produced primarily 
by activated monocytes and B cells, mediates pleiotropic bio- 
logic activities  in vitro and in vivo (for reviews see Pestka 
et al.,  1987; De Maeyer and De Maeyer-Guignard,  1988). 
In addition to its potent antiviral and antiproliferative  activi- 
ties,  IFN-ct  has  been  shown  to  influence  the  regional 
trafficking  of B  and  T  lymphocytes to peripheral  lymph 
nodes (Gresser et al.,  1981; Kalaaji et al.,  1988; Hein and 
Supersaxo,  1988; Mann et al., 1989). The hallmark of a cel- 
lular response to IFN-ot is the induction of a restricted num- 
ber of genes termed IFN-a-stimulated genes (ISG). Consid- 
erable insight  has recently been gained  into the molecular 
mechanisms  by  which  IFN-a  regulates  ISG  expression. 
Transcriptional  stimulation results from activation of a latent 
transcription  factor (IFN-stimulated gene factor 3, ISGF3) 
which recognizes a conserved cis-acting DNA sequence (the 
IFN-stimulated response element or ISRE) located within 
regulatory sequences of target genes (Friedman and Stark, 
1985; Levy et al., 1989; Fu, 1992a; Schindler et al., 1992). 
The protein products encoded by ISG have been implicated 
in  the  antiviral  and  antiproliferative  activities  of IFN-c~ 
(Pestka et al.,  1987; De Maeyer and De Maeyer-Guignard, 
1988); however, a role for ISG in lymphocyte adhesion and 
homing  has not been established. 
We present here the first evidence that IFN-ot regulates the 
expression  of the L-selectin homing  receptor by human  B 
lymphoid  cells.  The  surface  density  of  L-selectin  was 
markedly increased by IFN-c~ in the established human  B 
lymphoid Daudi cell line and in a subpopulation  of tissue- 
derived human B cells. In Daudi B cells, elevated L-selectin 
surface  expression  induced  by IFN-c~ correlated  directly 
with an increase in L-selectin mRNA steady state levels and 
enhanced binding to the L-selectin ligand phosphomonoester 
core polysaceharide (PPME) (Stoolman et al.,  1987; Sper- 
tini et al., 1991a,b). The regulation  of L-selectin mRNA by 
IFN-ot had  characteristics  similar  to that  of classical  ISG 
such as ISG15 and ISG54, including rapid kinetics of induc- 
tion, protein synthesis-independent induction,  and sensitiv- 
ity to inhibitors of tyrosine kinase activity. IFN-ot did not up- 
regulate L-selectin mRNA levels or cell surface expression 
in an IFN-resistant Daudi subclone which exhibits a defect 
in the signal transduction  pathway required for the transcrip- 
tional activation of ISG (Kessler et al., 1988). These results 
provide insight into the mechanisms  by which the cytokine 
IFN-c~ regulates L-selectin gene expression and further sug- 
gest that IFN-o~ may play a central  role in directing  the re- 
gional trafficking of B lymphocytes to peripheral  lymphoid 
tissues. 
Materials and Methods 
Cell Isolation and Cultures 
The CII-IFN growth-sensitive and the C12 IFN-resistant subelones of the 
human Daudi B lymphoblastoid cell line were kindly provided by Dr. A. 
Hovanessian (Institut Pasteur, Paris, France). C11 cells are highly sensitive 
to the antiproliferative effects of IFN-ct with >80% growth inhibition ob- 
served following exposure to 200 IU/rnl of IFN-c~ for 3 d whereas the C12 
subclone is resistant to IFN-cz  at concentrations as high as  1,000 IU/mi 
(Hovanessian et al., 1986; Pfeffer et al., 1987; Scarozza et al., 1992). Daudi 
cells  were  maintained  in  logarithmic  growth  (5-9  x  105  ceUs/ml)  in 
RPMI-1640 containing 10% FCS,  1% L-glntamine,  100 U/ml penicillin, 
100 #g/ml streptomycin, and 10  -5 M  2-mercaptocthanol. 
Enriched populations of human tonsillar B lymphocytes were isolated es- 
sentially as described previously  (Evans and Ozer,  1990;  Evans et al., 
1993). Cells were obtained by protocols approved by the Internal Review 
Board of Roswell Park Cancer Institute (Buffalo, NY). Briefly, single cell 
suspensions prepared from tonsil specimens obtained at the time of surgery 
(provided by Dr. Mark Volk, Children's Hospital of Buffalo, Buffalo, NY) 
were incubated 30 rain at 37"C in RPMM640 containing 10 mg/ml car- 
bonyl iron and iron-ingesting cells (e.g., monocytes) were removed using 
a magnet (Dynal, Inc., Fort Lee, NJ). Mononuclear cells (MNC) were then 
isolated by Ficoll-Hypaque  centrifugation.  Enriched populations of ton- 
sillar B  lymphocytes were obtained by rosctting with aminoethylisothio- 
uronium-treated sheep erythrocytes for 1 h at 4°C. The E-rosette-negative 
population was comprised of 85-95%  CD19  + B cells and <10% CD3 + T 
cells. Tonsillar lymphocyte populations were cultured in RPMI-1640 con- 
taining 2.5%  FCS,  1% L-glutamine,  100 U/ml penicillin, and 100 ~tg/ml 
streptomycin. 
Cytokines and Reagents 
Recombinant human IFN-c~ (2.2  x  10  s IU/mg) was kindly provided by Dr. 
P.  Trotta (Schering Corp.,  Bloomfield,  NJ).  Recombinant human IFN-? 
and IL4/3 were purchased from Genzyme Corp.  (Cambridge, MA).  The 
recombinant human cytokines IL-2, IL-4, IL-6 and TNF-c~ were purchased 
from R &  D Systems (Minneapolis, MN).  Highly purified low molecular 
weight (Mr =  12,000) B cell growth factor (BCGF) was purchased from 
Cellular Products (Buffalo, NY). Low molecular weight BCGF is a human 
T  cell product and is certified to be free of colony stimulating factor-l, 
IFN-%  IL-1,  and IL-2 activities.  Cycloheximide and staurosporine were 
purchased from Sigma Immunochemicals (St. Louis, MO). Genistein was 
purchased from GIBCO-BRL (Grand Island, NY). 
Monoclonal Antibodies 
The following murine monoclonal  antibodies specific  for the human 
L-selcctin  molecule and isotypc-matched  control  antibodies  were obtained 
commercially:  anti-Lcu-8  (Becton  Dickinson,  Sunnyvale,  CA), TQI (Coul- 
ter  Immunology,  Hialeah,  FL), and DREG-56 (AMAC, Inc.,  Westhrook, 
MA). The B lymphocyte-specific  monoclonal antibody  anti-CDl9-PE and 
an isotype  matched PE-conjngated control  antibody  were purchased from 
Becton Dickinson. 
Flow Cytometric  Analysis 
The cell  surface expression of L-selectin was determined by direct im- 
munofluorescence analysis as previously  described  (Evans et al.,  1990, 
1993). Briefly, cells (0.5  x  106 per sample) were washed in PBS/0.02% so- 
dium  azide,  and then incubated with 0.5  mg/ml  mouse  Ig  (Sigma  Im- 
munochcmicals) for 10 min at 4"C to block Fc receptor sites. Cells were 
then incubated with the appropriately titered FITC-conjugated monoclonal 
anti-Leu-8 for 30 min at 4°C, washed with PBS/0.02 % sodium azide, and 
then fixed in PBS containing 1% formaldehyde and analyzed immediately 
by flow cytometry.  FITC-conjugated  isotype matched murine antibodies 
that were unreactive with human leukocytes were used as negative controls. 
Samples were examined on a FACSean flow cytometer (Becton-Dickinson 
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lyzed  using  Consort  30  and  LYSYS software  (Becton-Diekinson Im- 
munocytometry Systems).  A  total of 5,000  events  were  analyzed and 
specific fluorescence intensity, reported as mean channel fluorescence based 
on a linear scale of 0-1,000 channels, was calculated by subtracting control 
fluorescence  values. 
Two-color immunofluorescence  analysis was performed to determine the 
effect of cytokines on L-selectin expression by tissue-derived human B lym- 
phocytes.  For these studies,  enriched populations  of B cells were stained 
simultaneously with anti-CD19-PE and anti-Leu-8-FITC  immediately after 
their isolation from tissue or following culture for 24 h in the presence or 
absence of IFN-~. F1TC- and PE-conjngated class-matched irrelevant con- 
trol antibodies were included in all experiments and used to define appropri- 
ate quadrants for data analysis.  Data from 30,000 events were collected on 
a FACScan flow cytometer using four-decade  logarithmic amplifiers  and 
analyzed  using  LYSIS software  (Becton-Dickinson  Immunocytometry 
Systems). 
PPME Binding Assay 
Lymphocyte binding of PPME, the phosphomonoester core from Hansen- 
ula holstii phosphomannan, has been described (Stoolman et al.,  1987; 
Spertini,  1991a,b). Briefly, Dandi B cells were washed once in RPMI 1640 
medium and then pretreated with the L-selectin-specific monoclonal anti- 
body TQ1 or an isotype  matched control antibody (10 #g/ml) for 30 rain 
at 4°C.  Without washing,  cells were then incubated with a  1:200 dilution 
of fluorescein-conjugated  PPME (generous girl of Dr. L. Stoolman, Univer- 
sity of Michigan, Ann Arbor, MI) for 30 rain at 4"C, and then analyzed 
immediately  by  flow  cytometry.  Fluorescence measurements of FITC- 
conjugated  PPME binding were made with logarithmic amplification. 
Confocal Immunofluorescence Microscopy 
Daudi B cells that had been prewashed with PBS/0.02 % sodium azide at 0°C 
we/'e stained with the combination of FITC-conjugated  anti-Leu-8 and un- 
conjugated TQ1 monoelonal antibodies (to amplify the immunofluorescent 
signal) for 30 rain, washed in PBS/0.02 % sodium azide,  and then stained 
an additional 30 mi  n with goat F(ab')2 ariti-mouse-Ig-FITC (Organon Tek- 
nika:Cappel, ~  Malyern, PAL)at a dilution of 1:30. AI! staining and fixing 
procedures were performed at 0°C in ~  presence of 0.02% sodium azide. 
Cells  were then fixed 30 min in 1% formaldehyde,  washed once in PBS/ 
0.02%  sodium azide,  cytocentrifuged  onto glass slidesi and'examined by 
confocal microscopy.  Confocal  laser scanning microscopy was performed 
using a Bio-Rad MRC-600 microscope (Bio-Rad Laboratories, Palo Alto, 
CA). An Argon ion laser adjusted at 488-nm wavelength was used for the 
analysis of fluorescein. The adjustment of the confocal system allows a field 
depth of"ol #m. The emitted signal was digitalized by Kalman filter collec- 
tion and each section was scanned five times. Black and white pictures from 
screen images were taken on Kodak T-MAX  100 film. 
L-Selectin eDNA Probe Construction 
Total RNA was isolated by the guanidium isothiocyanate  method (Chomc- 
zynski and Sacchi,  1987) from IFN-sensitive Daudi B ceils that had been 
treated with 500 IU/ml of recombinant IFN-c~ for 24 h. First strand eDNA 
was synthesized  by AMV reverse  transcriptase as described (Gubler and 
Hoffman,  1983). A 666-bp insert of the L-selectin gene was amplified using 
the polymerase chain reaction (PCR). L-selectin-specific primers designed 
from the published sequence (Tedder et ai.,  1989; Camerini et al.,  1989) 
were synthesized by the Roswell Park Cancer Institute Biopolymer Facility 
(Buffalo,  NY).  The 27-mer  upstream primer (GGAGAATTCGTATCTG- 
GAGAAGACTCTGC) contained a HindlII site and the downstream primer 
(CAGAAGCTTCTGAGCAGATGAAGGTAC) contained  an  EcoRI  site. 
Each PCR cycle consisted of a denaturing step at 92°C for 1 min, an anneal- 
ing step at 55°C for 1 rain, and an extension step at 72°C for 1 min. A total 
of 25 cycles  were  performed.  The insert was  subcloned into pGEM4Z 
(Promega,  Madison, WI). The sequence of the L-selectin eDNA insert was 
confirmed by dideoxy  sequencing. 
RNA Blot Hybridization 
Total RNA (30 #g/sample), isolated from IFN-a-treated and -untreated 
Daudi cells as described (Chomczynski and Saechi, 1987), was denatured 
with glyoxai,  electrophoresed on a  1.2% agarose gel, and transferred to 
Zetaprobe membrane (Bio-Rad Labs, Richmond, CA). The blot was then 
hybridized with 3~P-labeled eDNA inserts for L-selectin, ISG15, or ISG54 
(eDNA probes for ISG15 and ISG54 were kindly provided by Dr. D. Levy, 
New York University, New York) as described (Airman et al., 1990). Inserts 
were labeled using the random primer technique to a specific activity of 
109 cpm/#g DNA. Blots were simukaneously probed with a eDNA insert 
for triose phosphate isomerase (TPI) (kindly provided by Dr.  L. Maqnat, 
Roswell Park Cancer Institute, Buffalo, NY) as a loading control. Washed 
membranes were subjected  to autoradiography over a 48-h period. Scan- 
ning densitometry of the autoradiographs was performed using a Molecular 
Dynamics Fast Scan (Molecular Dynamics, Sunnyvale,  CA). 
Results 
IFN-a Induces L-selectin Cell  Surface Expression by 
Human B Lymphoid Cells 
Analysis of the effect of IFN-c~ on the cell surface expression 
of L-selectin was first performed using established human B 
lymphoid Daudi cell lines that were either sensitive or resis- 
tant to the antiproliferative activity of IFN-a (Hovanessian 
et al., 1986; Pfeffer et al., 1987; Scarozza et al., 1992; Evans 
et al.,  1993).  The Cll  IFN-a-sensitive and C12  IFN-c~- 
resistant Daudi subclones express similar numbers of high 
affinity IFN-cx receptors (Pfeffer et al., 1987); however, the 
IFN-resistant subclone is characterized by the failure to in- 
duce selected IFN-cx-stimulated genes or ISG in response to 
IFN-ot (Tiwari et al., 1987; Kessler et al., 1988; Wang et al., 
1993). To examine the effect of IFN-u on the cell surface ex- 
pression of the L-selectin peripheral lymph node homing 
receptor, IFN-sensitive and -resistant Daudi B cells were in- 
cubated for 24 h in medium alone or in the presence of 200 
IU/ml of recombinant human IFN-a. L-selectin expression 
was determined by flow cytometric analysis of cells stained 
with the FITC-conjugated L-selectin-specific monoclonal 
antibody anti-Leu-8. Anti-Leu-8 binds to the NH~-terminal 
•  extracellular lectin domain of the L-selectin molecule (Cam- 
erini et al., 1989; Tedder et al., 1990; Spertini et al., 1991b). 
The data shown in Fig.  1 indicate that the IFN-sensitive 
Daudi subclon  c constitutively expresses low but detectable 
levels of L-selectin. Incubation of IFN-sensitive Daudi cells 
with IFN-a for 24 h resulted in a marked increase in the cell 
surface density of the L-selectin homing receptor. In con- 
trast, IFN-resistant Daudi B cells express low to nondetect- 
able levels of L-selectin and incubation with IFN-ot failed to 
markedly increase the cell surface density of this molecule 
in this cell line (Fig. 1). Similar results were obtained using 
two additional monoclonal antibodies, DREG-56 and TQ1 
(data not shown), which also recognize epitopes within the 
extracellular lectin domain of L-selectin (Kishimoto et al., 
1990;  Spertini et al.,  1991b). 
Confocal  scanning  microscopy  confirmed  that  IFN- 
sensitive Daudi B cells constitutively express low but de- 
tectable levels of L-selectin at their surface (Fig. 2). A sig- 
nificant increase in the cell surface density of this adhesion 
molecule could be detected by confocal microscopy follow- 
ing incubation of Daudi cells for 24 h  with IFN-ot.  It is 
notable that a nonrandom distribution of L-selectin was ob- 
served on the surface of IFN-ot-treated Daudi B lymphoid 
cells.  Similar punctate  immunofluorescence staining pat- 
terns of L-selectin have recently been described in neutro- 
phils using confocal microscopy (Erlandsen et al., 1993). In 
this previous report, scanning electron microscopy revealed 
that cell surface L-selectin was localized primarily on the 
tips of microvilli or membrane ruffles. 
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Figure 1.  IFN-a increases L-selectin surface expression on IFN- 
sensitive  Daudi  B  lymphoid cells.  IFN-sensitive and  -resistant 
Daudi B cells were incubated 24 h in either medium alone or in the 
presence  of 200 IU/ml of IFN-a.  Cells were then stained with 
FITC-conjugated anti-Leu-8  monoclonal antibody (A) or an iso- 
type matched FITC-labeled control  antibody  (B)  and analyzed 
using a FACScan. The mean channel fluorescence (MCF) of the 
L-selectin signal is indicated in each panel (FITC-labeled-Ig con- 
trol values have been subtracted). 
The effect of IFN-a on L-selectin expression by tissue- 
derived human  B  lymphocyte populations  was  examined 
using two-color flow cytometric analysis. In general it has 
been difficult to evaluate the effect of cytokines on L-selectin 
expression by primary human lymphocytes since culture of 
these lymphocyte populations in medium alone, in the ab- 
sence of exogenous cytokines, causes a marked increase in 
L-selectin  expression  (Tedder  et  al.,  1990;  Salmi  and 
Jalkanen,  1992;  S.  S.  Evans,  unpublished  observations). 
The molecular basis for this culture-associated increase in 
L-selectin expression is not understood. In the present study, 
lymphocytes were cultured in medium containing low con- 
centrations of FCS  (i.e.,  2.5%)  to  minimize the level of 
spontaneous increase in L-selectin expression as described 
(Salmi and Jalkanen,  1992).  It should be noted, however, 
that in some experiments reduction of FCS concentrations 
did not prevent the high level of culture-associated increase 
in L-selectin expression; the effects of IFN-a on L-selectin 
expression were not evaluated under these conditions. 
In the experiment shown in Fig. 3, a majority ofB lympho- 
cytes isolated from human tonsil were found to be L-selectin 
negative. Following incubation for 24 h with IFN-ot, 20 % of 
tonsillar B cells became L-selectin positive while only 9% 
expressed L-selectin after culture in medium alone (Fig. 3). 
A similar increase in L-selectin expression by a small sub- 
population of tonsillar B cells was observed in multiple ex- 
periments involving specimens from different individuals. 
Moreover, ,~10-15 % of B cells within human bone marrow, 
spleen, and peripheral blood were found to increase L-selec- 
tin expression in response to IFN-ot (data not shown).  Al- 
though the proportion of tissue-derived B cells responding 
to IFN-a appeared to be relatively restricted, it is of  note that 
the L-selectin density on IFN-ot-responsive Daudi-B cells 
and tissue-derived B  cells was  comparable with that nor- 
mally found on blood lymphocytes which are functionally 
capable of trafficking to peripheral lymph nodes in vivo. Be- 
cause of the relatively uniform increase in L-selectin expres- 
sion by Daudi B cells in response to IFN-ot, this cell line was 
used as a model in subsequent studies to investigate further 
IFN-o~ regulation of L-selectin expression. 
Several other cytokines are known to influence the expres- 
sion of adhesion molecules on diverse cell types. For exam- 
ple,  tumor  necrosis  factor-oL (TNF-ot)  and  intedeukin-1/3 
(IL-I~ have been demonstrated to increase the expression of 
the vascular selectin ELAM-1 (or E-selectin) as well as the 
vascular cell adhesion moleculeq (VCAM-1) by human um- 
bilical chord endothelial cells (Osborn et al., 1989). TNF-o~, 
IL-1/3, and IFN--y have also been shown to induce intercellu- 
lar adhesion molecule-1  (ICAM-1)  cell surface expression 
and mRNA levels in cells of multiple lineages (Pober et al., 
1986; Simmons et al.,  1988). Therefore, the effect of these 
and other cytokines on L-selectin expression by IFN-sensi- 
tive Daudi B cells was examined. Daudi cells were incubated 
24 and 48 h with biologically active concentrations of IFN-u, 
IFN-%  TNF-a, IL-1/3, IL-2, IL-4, IL-6, and low molecu- 
lar weight B cell growth factor (BCGF) and the relative ex- 
pression of L-selectin was  determined by flow cytometry 
(Fig. 4). Again, IFN-ot significantly upregulated L-selectin 
expression as indicated by a major shift in specific fluores- 
cence  intensity  of  cells  stained  with  FITC-conjugated 
Figure  2.  Confocal  immunofluores- 
cence microscopy  of Daudi  B  lym- 
phoid cells. IFN-sensitive Daudi cells 
were  incubated 24 h in medium alone 
(a) or in the presence of 500 IU/ml of 
IFN-(x (b) and then stained with mu- 
rine  monoclonal  antibodies  specific 
for L-selectin (FITC-conjugated anti- 
Leu-8 and TQ1) in combination with 
goat  F(ab'h  anti-mouse-IgG-FITC. 
All  staining  and  fixation procedures 
were performed at 0°C in the presence 
of 0.02% sodium  azide.  Cells  were 
subsequently  fixed in  1%  formalde- 
hyde and then cytocentrifuged onto glass slides and examined by confocal microscopy. Arrows indicate punctate surface staining of L-selec- 
tin. Immunofluorescence was not detected using a FITC-conjugated isotype matched control antibody or goat F(ab'h  anti-mouse-IgG- 
FITC secondary antibodies (not shown). Bar, 25 t~m. 
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Figure 3. IFN-ot increases L-selectin surface expression by a sub- 
population of human tonsillar B lymphocytes. Enriched tonsillar B 
lymphocyte populations (>90%  CD19  +) were stained simultane- 
ously with the B cell-specific monoclonal antibody anti-CD-19-PE 
and the L-selectin-specific monoclonal antibody anti-Leu-8-FITC 
either immediately after isolation from tissue or following culture 
for 24 h in the absence or presence of 500 IU/ml of IFN-a. Total 
B cell recovery was not affected by culture with IFN-ot. L-selectin 
expression is depicted only for the CD19  + B cell population. The 
hatched histograms represent the background fluorescence of cells 
stained with a FITC-labeled isotype matched negative control anti- 
body. The frequency of L-selectin-positive B cells (designated by 
region 1) is shown. The relative number of L-selectin-positive B 
cells at the time of isolation from tissue (n) or following culture in 
the absence (g~) or presence (=) of IFN-a is indicated in the inset. 
Results are representative of four independent experiments. 
anti-Leu-8. On the other hand, IFN-'r, TNF-c~, IL-1/3, IL-2, 
IL-4,  IL-6,  and  low  molecular  weight  BCGF  did  not 
markedly alter the cell surface density of  L-selectin on Dandi 
B lymphoid cells over a 48-h period. These results are con- 
sistent with recent studies indicating that physiologic con- 
centrations of IL-1, IL-3, IL-4, IL-5, IL-6, IFN-% and TNF 
fail to significantly alter L-selectin cell surface expression by 
human lymphocytes derived from the bone marrow or pe- 
ripheral blood (Tedder et al.,  1990;  Salmi and Jalkanen, 
1992; Picker et al.,  1993). 
IFN-c¢ was also found to induce L-selectin expression by 
Daudi  B  ceils  in a  time-  and dose-dependent manner.  A 
significant increase in the cell surface density of L-selectin 
could be detected 9  h  after the addition of IFN-ct and by 
24 h,  L-selectin expression was  increased  approximately 
ten-fold  above  background  levels  (Fig.  5).  Moreover, 
elevated L-selectin cell surface expression was  maintained 
during continuous exposure to IFN-a for 72 h. In untreated 
Daudi cells, the basal level of L-selectin expression decreased 
over a 72-h period as cells approached confluence and Go/ 
G~ growth arrest (Scarozza et al.,  1992).  Previous studies 
have similarly noted an inverse relationship between L-selec- 
tin cell surface expression by cell lines and cell culture con- 
centration (Tedder et al., 1990). Our studies further indicate 
that maximal induction of L-selectin occurred at physiologic 
concentrations of IFN-cx (i.e., -g<100 IU/ml) and was inhibited 
by the protein synthesis inhibitor cycloheximide (Fig.  6). 
L-selectin induction was also abrogated by the broad spectrum 
protein kinase inhibitor staurosporine and by the tyrosine 
kinase-specific inhibitor genistein (Fig.  6).  These protein 
synthesis and protein kinase inhibitors also down-regulated 
the basal expression of L-selectin at the cell surface of un- 
treated Daudi cells, suggesting that turnover of  the L-selectin 
molecule in the plasma membrane occurs continuously over 
a 24-h period. 
IFN-c~ Increases the Steady-state Level of 
L-selectin mRNA 
There are several possible mechanisms which could account 
for the increased cell surface expression of L-selectin ob- 
served in IFN-treated Daudi cells. Since L-selectin is known 
to be continuously shed from the cell surface of  lymphocytes 
(Jung and Dailey,  1990;  Schleiffenbaum et al.,  1992), up- 
regulation of L-selectin could occur as a result of stabiliza- 
tion of L-selectin in the plasma membrane.  Alternatively, 
IFN-a may regulate L-selectin synthesis in Daudi B  lym- 
phoid cells, as suggested by evidence that cycloheximide in- 
hibits the IFN-a-induced increase in L-selectin cell surface 
expression. This question was addressed by examining the 
effect of IFN-a on L-selectin mRNA accumulation in IFN- 
sensitive and -resistant Daudi cells. Northern blot analysis 
of total  RNA  isolated  from untreated  IFN-sensitive  Cll 
Daudi cells indicated that these cells contain detectable lev- 
els of the 2.4-kb L-selectin mRNA transcript (Fig. 7 a), con- 
sistent with the flow cytometric data shown in Fig. 1. Follow- 
ing incubation with IFN-o~, increased steady state levels of 
L-selectin mRNA were detectable within 3 h, reached maxi- 
mum levels by  12 h,  and  remained elevated over a  72-h 
period during continuous exposure to IFN-ct. Scanning den- 
sitometry  of the  autoradiograph  revealed  that  L-selectin 
mRNA levels increase approximately 14-fold after exposure 
to IFN-ct for 12 h (Fig. 7 b). In contrast, the IFN-resistant 
C12 Daudi  subclone,  which express low to nondetectable 
levels of L-selectin at the cell surface (Fig.  1),  contained 
negligible levels of L-selectin mRNA in both the untreated 
and 24-h IFN-a-treated samples (Fig. 7). In addition, other 
cytokines such  as  TNF-c~ and IFN-3, had  relatively little 
effect on L-selectin mRNA levels over a 48-h period in IFN- 
sensitive or -resistant Daudi cells (data not shown).  Taken 
together, these data support the conclusion that IFN-t~ in- 
duction of L-selectin surface expression results  from in- 
creased synthesis of this homing receptor. 
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Figure  4.  L-selectin  surface 
expression  is  selectively  in- 
duced by the cytokine IFN-c~. 
IFN-sensitive  Daudi  B  cells 
were incubated 24 or 48 h in 
medium alone or medium sup- 
plemented  to  a  final  con- 
centration  of  500  IU/ml  of 
IFN-c~, 500 IU/ml of IFN-  7, 
100  ng/ml  of  TNF-cx,  10 
IU/ml of IL-1/3, lO0 IU/ml of 
IL-2, 5 ng/ml of IL-4, 5 ng/rnl 
of  IL-6,  or  10%  (vol/vol) 
low molecular weight BCGE 
Ceils were then stained  with 
FITC-conjugated  anti-Leu-8 
monoclonal antibody and the 
relative density  of L-selectin 
on Daudi  B cells  was deter- 
mined by flow cytometric anal- 
ysis.  Values represent  mean 
-t-  SD  of three  independent 
experiments.  Differences be- 
tween control cells and IFN-a- 
treated cells were highly sig- 
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Figure  5.  Kinetics of L-selectin cell surface induction by IFN-~x. 
IFN-sensitive  Daudi B cells, plated at an initial concentration  of 
Two important features have been identified regarding the 
signal transduction pathway utilized by IFN-ot to transcrip- 
tionaUy induce ISG expression. Transcriptional activation of 
ISG has been shown to occur in the absence of ongoing pro- 
tein synthesis and to be dependent on tyrosine kinase activ- 
ity (Levy et al.,  1988;  Schindler et al.,  1992;  Fu,  1992a; 
David et al.,  1993;  Wang et al.,  1993).  Therefore, to de- 
termine  if this  IFN-ot  signal  transduction  pathway  could 
play a role in the regulation of L-selectin gene expression, 
we examined the effects of cycloheximide and genistein on 
IFN-~x induction of the mRNA steady state levels of L-selec- 
tin  and  two  well-characterized  IFN-ot-inducible  genes, 
ISG15 and ISG54, which encode 15- and 54-kD cytoplasmic 
proteins, respectively (Levy et al.,  1988,  1989; Kessler et 
al., 1988). The data shown in Fig. 8 indicate that the mRNA 
levels of ISG15, ISG54,  and L-selectin were markedly in- 
duced following incubation for 4 or 8 h with IFN-ot. More- 
over, upregulation by IFN-c~ of ISGI5, ISG54, and L-selectin 
mRNA levels occurred in the presence of cycloheximide but 
was significantly reduced in genistein-treated cells. Taken to- 
gether with evidence that IFN-c~ did not induce L-selectin 
mRNA levels in the IFN-resistant Daudi subclone character- 
ized  by a  defect in  the  transcriptional  induction  of IFN- 
a-stimulated genes (ISG) (Tiwari et al., 1987; Kessler et al., 
6 x  1@ cells/ml, were incubated in medium alone (o) or with 200 
IU/ml oflFN-a (o) for the indicated time intervals. Cells were then 
stained  with  FITC-conjugated  anti-Leu-8 monoclonal  antibody 
and L-selectin expression was assessed by flow cytometry. 
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Figure 6. L-selectin induction by IFN-~ is blocked by inhibitors of 
protein  synthesis  and  of protein  kinase  activity.  IFN-sensitive 
Daudi B cells were pre-incubated 30 rain in medium alone (•) or 
in the presence of 50/~M  cycloheximide (o), 500 nM staurospo- 
rine (,,), or 185/zM genistein (A) before the addition of IFN-t~ at 
200 IU/ml. Following culture  for an additional  24 h, cells were 
stained with the FITC-eonjugated anti-Len-8 monoelonal antibody 
and analyzed by flow cytometry.  Cell viability was >85 % under 
these conditions. 
1988; Wang et al., 1993), these data strongly suggest that the 
regulation  of classical ISG mRNA and  L-selectin mRNA 
levels by IFN-o~ involves common signalling pathways. 
IFN-a Augments L-selectin-mediated Binding to the 
Carbohydrate Substrate PPME 
L-selectin binds via its NH2-terminal lectin domain to car- 
bohydrate-rich ligands on HEV (Imai et al.,  1991; Lasky et 
al.,  1992b) and this interaction can be inhibited by specific 
polysaccharides rich  in mannose 6-phosphate such as the 
phosphomonoester  core  polysaccharide  (PPME)  derived 
from yeast (Stoolman et al., 1987).  PPME has also been con- 
jugated with fluorescein to assess L-selectin-binding activ- 
ity without interference from other adhesion pathways (Sper- 
tini et al., 1991a,b). Therefore, to determine if the L-selectin 
molecules induced by IFN-ot were functionally capable of 
binding oligosaccharide ligands, flow cytometry was used to 
assess PPME-FITC binding to Daudi B lymphoid cells (Fig. 
9).  The  specificity  of PPME  binding  to  L-selectin  was 
confirmed by the ability of the L-selectin-specific monoclo- 
nal antibody TQ1  to inhibit PPME binding to cells.  In the 
absence of IFN-ot, PPME-FITC binding to the IFN-sensitive 
Daudi subclone could not be detected despite the expression 
of low levels of cell  surface L-selectin,  suggesting that  a 
Figure 7.  Northern  blot analysis of the expression of L-selectin 
mRNA in  Daudi  B  lymphoid  ceils.  (A)  IFN-sensitive  Cll  and 
-resistant  C12 Daudi B ceils  were incubated with 500  IU/ml of 
recombinant  human IFN-, for the indicated time intervals,  har- 
vested, and total cellular RNA was prepared.  30/zg of each sample 
were electrophoresed through an agarose gel and transferred to a 
Zetaprobe membrane  and the blot was hybridized with radiolabeled 
L-selectin  and  triose  phosphate  isomerase  (TPI) eDNA inserts. 
The 2.4 kb L-selectin transcript  and the 1.4-kb TPI transcript  are 
indicated. (B) The same RNA blot was quantified by densitometric 
scanning and normalized with respect to TPI mRNA to*correct for 
small variations in the amount of input RNA. The relative expres- 
sion  of L-seleetin  mRNA  was  calculated  based  on  L-selectin 
mRNA levels detected in untreated IFN-sensitive Cll cells. 
threshold level of L-selectin is necessary to measure PPME 
binding  by  flow  cytometry.  Incubation  of  IFN-sensitive 
Dandi B lymphoid cells with IFN-o~ resulted in the marked 
enhancement  of  L-selectin-mediated  binding  to  PPME 
which correlated directly with the increased cell surface den- 
sity of L-selectin in these cells. In contrast, IFN-ot did not 
enhance binding of the FITC-conjugated PPME substrate by 
the IFN-resistant Daudi subclone. 
Discussion 
In this report we provide the first evidence of a  role for a 
specific cytokine, IFN-ct, in regulating the expression of the 
L-selectin peripheral lymph node homing receptor by hu- 
man B lymphoid cells. IFN-ot was shown to induce a five to 
10-fold increase in the cell surface density of L-selectin in 
the IFN-ot sensitive Daudi B lymphoid cell line. A  marked 
increase in L-selectin density in response to IFN-ot was also 
observed in subpopulations of B cells isolated from human 
tonsil, spleen, peripheral blood, and bone marrow. The den- 
sity of L-selectin expressed on IFN-c~-responsive Dandi B 
cells and tissue-derived B  cells was comparable with that 
found on human lymphocytes which are functionally capable 
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Figure 9.  IFN-u increases L-selectin-mediated binding of FITC- 
conjugated PPME to IFN-sensitive Dandi B Lymphoid cells. IFN- 
sensitive and IFN-resistant Daudi ceils were incubated 24 h in the 
absence (control) or presence of 500 IU/ml of IFN-a. Ceils were 
then incubated with either the L-selectin-specific monoclonal anti- 
body TQ1 (--) or an isotype matched control Ig (--) before the addi- 
tion of FITC-conjugated PPME and fluorescence intensity of cell 
staining was analyzed by flow cytometry. 
Figure 8. Effect of cycloheximide and genistein on L-selectin and 
ISG expression induced by IFN-c~  treatment of  IFN-sensitive Daudi 
ceils. (A) IFN-sensitive Daudi B cells were pre-ineubated 30 min 
in medium alone or in the presence of  50 #M cycloheximide  (CHX) 
or 185 #M genistein before the addition of 500 IU/ml of IFN-~. 
After incubation for 4 or 8 h, total RNA was isolated and 30 #g 
of each sample were electrophoresed through an agarose gel and 
transferred to a Zetaprobe membrane. The blot was hybridized with 
radiolabeled ISG54, ISG15, L-seleetin, and TPI eDNA inserts. The 
ISG54 (2.8 kb), ISG15 (0.4 kb), L-selectin (2.4 kb), and TPI (1.4 
kb) transcripts are indicated. (B) The RNA blots were quantified 
by densitometric  scanning and normalized with respect to TPI 
mRNA to correct for small variations in the amount of input RNA. 
The relative expression of ISG54, ISG15, and L-selectin mRNA 
was calculated based on the level of expression of these genes in 
IFN-c~-treated Daudi B ceils. 
of trafficking to peripheral lymph nodes. It is of interest that 
the  response  to  IFN-o~ was  restricted  to  approximately 
10-15 % of  primary human B lymphocyte  populations. These 
results may reflect a differential response to IFN-ot by tissue- 
derived B cells which are highly heterogeneous with respect 
to stage of maturation, differentiation, and activation. The 
relatively  uniform  increase  in  L-selectin  expression  by 
Daudi B cells in response to IFN-a suggests that this estab- 
lished cell line could serve as valuable model in which to ex- 
amine the molecular mechanisms by which L-selectin ex- 
pression and synthesis are regulated. 
Upregulation of L-selectin cell surface expression by IFN- 
sensitive Daudi cells in response to IFN-o~ was shown to be 
sensitive to cycloheximide and  was  temporally correlated 
with  an  increase  in  the  steady-state  levels  of L-selectin 
mRNA. These data are consistent with the conclusion that 
IFN-ot regulates the synthesis of this homing receptor. Con- 
siderable insight has recently been gained into the signal 
transduction pathway utilized by IFN-ot to transcriptionally 
activate ISG and it is possible that these mechanisms play a 
role in controlling L-selectin gene expression in human B 
lymphoid cells.  Receptor occupancy by IFN-a  has  been 
shown to rapidly trigger the activation of a transcriptional 
factor termed  ISGF3ot  (interferon-stimulated gene  factor 
3o~) which is comprised of  three cytoplasmic proteins of 113, 
91, and 84 kD (Fu et al., 1992b). ISGF3a activation involves 
phosphorylation  of tyrosine  residues  on  all  three  of its 
subunits and their association with a 48-kD DNA-binding 
protein  termed  ISGF3,y  (Levy et  al.,  1989;  Fu,  1992a; 
Schindler et al., 1992; Fu, 1992a; David et al., 1993). Fol- 
lowing activation, this multimeric ISGF3 complex translo- 
cates to the nucleus where it elicits a transcriptional response 
by binding with high affinity to specific IFN-stimulated re- 
sponse elements (ISRE) located in the promoter region of  in- 
ducible  genes  such  as  ISG15,  ISG54,  and  the 6-16  gene 
(which encode proteins of 15, 54, and 12 kD, respectively) 
(Friedman and Stark,  1985; Levy et al.,  1988). 
The mechanism by which IFN-ot increases the accumula- 
tion  of L-selectin mRNA  levels  in  Daudi  cells  was  not 
directly examined in the present study.  Thus, upregulation 
could occur as a  result of transcriptional activation of the 
L-selectin gene or increased stability of L-selectin mRNA. 
However, several notable similarities exist between the regu- 
lation  by  IFN-a  of well  characterized ISG  (i.e.,  ISG15, 
ISG54) and L-selectin gene expression, suggesting that in- 
duction of these genes involves common signal transduction 
pathways.  Specifically, the kinetics of L-selectin mRNA in- 
duction by IFN-ot parallels the time course of induction of 
mRNAs encoded by ISG15, ISG54 and the 6-16 gene in the 
IFN-sensitive Daudi B cell line (Tiwari et al., 1987; Kessler 
et al., 1988; Wang et al.,  1993). Induction of the L-selectin 
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3 h following exposure to IFN-ot and elevated levels of these 
genes are maintained for periods greater than  12 h in the 
IFN-sensitive Daudi B lymphoid cell line.  It is of note that 
IFN-ot-induced upregulation  of L-selectin mRNA preceded 
the characteristic IFN-o~-mediated  G0/G, arrest that occurs 
over a 24--48-h period in Daudi cells (Einat  et al.,  1985; 
Scarozza et al,,  1992),  indicating  that modulation of this 
homing  receptor gene cannot be attributed  to an  overall 
change in cell cycle distribution.  Our data further indicate 
that induction by IFN-ot of L-selectin, ISG15, and ISG54 
mRNA steady state levels in Daudi cells is dependent on 
tyrosine kinase activity but does not require ongoing protein 
synthesis,  two hallmarks  of the signal transduction  pathway 
utilized by IFN-ot to transcriptionally  activate ISG. Finally, 
IFN-ot failed to induce L-selectin mRNA levels or cell sur- 
face expression in the IFN-resistant Daudi subclone.  This 
IFN-resistant  Daudi  subclone is  characterized  by abnor- 
mally low levels of nuclear ISGF3 activity following IFN-o~ 
binding to cell surface receptors and low to non-detectable 
levels of ISG15, ISG54, and the IFN-inducible mRNA 561 
(Tiwari et al., 1987; Kessler et al., 1988; Wang et al., 1993). 
Taken  together,  these data are consistent with a model in 
which regulation of L-selectin gene expression by IFN-ot in- 
volves direct activation  by the ISGF3 transcriptional  factor. 
To date, the promoter region and transcription  initiation site 
of the L-selectin gene have not been identified  (Ord et al., 
1990) and therefore it remains to be determined if ISRE con- 
sensus sequences are present in the regulatory region of the 
L-selectin gene. 
The increase in the cell surface density of L-selectin on hu- 
man B lymphoid cells in response to IFN-ot was also shown 
to correlate with an increase in L-selectin-mediated bind- 
ing  to the mannose-6-phosphate-rich  carbohydrate ligand 
PPME.  Previous studies  have established that the level of 
PPME binding directly correlates with the ability oflympho- 
cytes to adhere to peripheral lymph node HEV (Stoolman 
et al.,  1987; Spertini et al., 1991a,b). Thus, upregulation  of 
L-selectin by IFN-ot would be expected to enhance the entry 
of lymphocytes into peripheral lymph nodes via HEV. Evi- 
dence that  IFN-ot affects lymphocyte entry into peripheral 
lymph nodes has been described in sheep and rodent models. 
In  these  studies,  systemic  administration  of IFN-tx  over 
periods greater than 6 h was shown to result in a decrease 
in the total number of B and T lymphocytes in the circulation 
and an associated increase in both the uptake and retention 
of lymphocytes within peripheral lymph nodes (Gresser et 
al.,  1981; Kalaaji et al.,  1988; Hein and Supersaxo,  1988; 
Mann et al., 1989). Moreover, in short-term homing studies, 
preincubation of rodent lymphocytes with IFN-ot/B prior to 
intravenous  transfer into syngeneic hosts increased their rate 
of entry into peripheral lymph nodes without affecting their 
localization in Peyer's patches (Kimber et al., 1987). In con- 
trast, enhanced migration  of nontreated  lymphocytes to pe- 
ripheral  lymph nodes was  not observed when these cells 
were  injected  into  IFN-ot-treated  mice  (Gresser  et  al., 
1981). These results, taken together with the data of  the pres- 
ent report, support the hypothesis that IFN-c~ influences the 
regional  trafficking  of lymphocytes to  peripheral  lymph 
nodes, in part, by acting at the lymphocyte level to regulate 
L-selectin expression. 
It remains to be determined if IFN-a can account for the 
differential regulation of L-selectin expression in B cell sub- 
sets observed in vivo. Within the bone marrow, immature  B 
cells (CDllYCD20-CD19  ÷) have been shown to be L-selec- 
tin  negative  while  more  mature  B  cells  (CD10-CD21Y- 
CD19 ÷)  reportedly  express  high  levels  of  this  homing 
receptor (Kansas  and  Dailey,  1989;  Salmi  and  Jalkanen, 
1992).  In the peripheral blood, approximately  80%  of pe- 
ripheral blood B cells express high levels of L-selectin and 
naive B  cells have  been identified  within  this  population 
(Kansas et al., 1985b; Tedder et al., 1990). The numerically 
minor L-selectin-negative peripheral blood B cell popula- 
tion has been shown to be functionally  more mature as de- 
termined  by the production  of antibodies  in  response  to 
helper T cells or mitogens (Kansas et al., 1985b). In second- 
ary  lymphoid tissues  (e.g.,  lymph  nodes,  tonsil,  Peyer's 
patches), germinal center B cells have been also shown to ex- 
press low to non-detectable levels of L-selectin (Reichert et 
al.,  1983;  Kansas  et al.,  1985a).  B  cells  which  traffick 
through  peripheral lymphoid tissues have been proposed to 
continuously alter their expression of tissue-restricted  hom- 
ing receptors during their conversion from sessile to migra- 
tory cells or as they enter the circulating  memory pool. 
Based on evidence obtained in the present study, it is tempt- 
ing  to  speculate that  IFN-a,  present  in  lymphoid tissue 
microenvironments,  differentially  regulates  L-selectin  re- 
ceptor expression on human B lymphocytes. There is little 
information  available  regarding  the physiologic  concentra- 
tion of cytokines including  IFN-at in B lymphoid compart- 
ments in vivo, in part because of the difficulty of assessing 
the concentration of cytokines in local environments  within 
cell-to-cell contact regions.  Future studies  are expected to 
provide further insight  into the molecular mechanisms by 
which IFN-a regulates L-selectin gene expression by B lym- 
phocytes and the physiologic role of IFN-ot in controlling the 
homing behavior of human B lymphocytes in vivo. 
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